Our top pick for
Histogen Inc is a biotechnology business based in the US. Histogen shares (HSTO) are listed on the NASDAQ and all prices are listed in US Dollars. Histogen employs 22 staff and has a trailing 12-month revenue of around USD$3.1 million.
|Latest market close||USD$1.24|
|52-week range||USD$0.2303 - USD$5|
|50-day moving average||USD$1.3858|
|200-day moving average||USD$2.261|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-3.0506|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||40.91%|
|1 month (2020-12-17)||4.20%|
|3 months (2020-10-15)||-38.00%|
|6 months (2020-07-15)||-57.97%|
|1 year (2020-01-15)||197.50%|
|2 years (2019-01-15)||-31.87%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-15)||1.65|
|Revenue TTM||USD$3.1 million|
|Gross profit TTM||USD$3.1 million|
|Return on assets TTM||-82.09%|
|Return on equity TTM||-338.53%|
|Market capitalisation||USD$18 million|
TTM: trailing 12 months
There are currently 74,916 Histogen shares held short by investors – that's known as Histogen's "short interest". This figure is 85.4% up from 40,402 last month.
There are a few different ways that this level of interest in shorting Histogen shares can be evaluated.
Histogen's "short interest ratio" (SIR) is the quantity of Histogen shares currently shorted divided by the average quantity of Histogen shares traded daily (recently around 576276.92307692). Histogen's SIR currently stands at 0.13. In other words for every 100,000 Histogen shares traded daily on the market, roughly 130 shares are currently held short.
However Histogen's short interest can also be evaluated against the total number of Histogen shares, or, against the total number of tradable Histogen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Histogen's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Histogen shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Histogen shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Histogen.
Find out more about how you can short Histogen stock.
We're not expecting Histogen to pay a dividend over the next 12 months.
Histogen's shares were split on a 1:10 basis on 27 May 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Histogen shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Histogen shares which in turn could have impacted Histogen's share price.
Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.